CSF-biomarkers in de diagnostiek van de ziekte van Alzheimer

Bronnen:

1. Wilde A de, Maurik IS van, Kunneman M, et al. Alzheimer’s biomarkers in daily practice (ABIDE) project: rationale and design. Alzheimers Dement (Amst). 2017;6:143-51.,Kunneman M, Pel-Littel R, Bouwman FH, et al. Patients’ and caregivers’ views on conversations and shared decision making in diagnostic testing for Alzheimer’s disease: The ABIDE project. Alzheimers Dement (NY). 2017;3:314-22.,Teunissen C. A consensus protocol for standardisation of cerebrospinal fluid collection and biobanking. Neurology. 2009;73:1914-22.,Teunissen CE, Otto M, Engelborghs, et al. White paper by the Society for CSF Analysis and Clinical Neurochemistry: overcoming barriers in biomarker development and clinical translation. Azheimer Res Ther. 2018;10:30-7.,Su Y, Blazey TM, Owen CJ, et al. Quantitative amyloid imaging in autosomal dominant Alzheimer’s disease: results from the DIAN Study Group PLoS One. 2016;11:e0152082.